Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

3.49
Delayed Data
As of Oct 19
 +0.02 / +0.58%
Today’s Change
1.93
Today|||52-Week Range
3.77
+64.62%
Year-to-Date
Amgen Label Expansion Application for Prolia Accepted by FDA
Oct 10 / Zacks.com - Paid Partner Content